1-10 of 10
Omar Abdel-Wahab
Close
Sort by
Journal Articles

Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms

Clinical Trials & Observations
Benjamin H. Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab, Mariko Yabe, Young Rock Chung, Gilad Itchaki, Maayan Ben-Sasson, Vered A. Asher-Guz, David Groshar, Seyram A. Doe-Tetteh, Tina Alano, David B. Solit, Ofer Shpilberg, Eli L. Diamond, Roei D. Mazor
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7319–7328.
https://doi.org/10.1182/bloodadvances.2022009349
Published: 2023
Includes: Supplemental data
Journal Articles

Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type

Jean-François Emile, Zofia Hélias-Rodzewicz, Benjamin H. Durham, Sébastien Héritier, Malik da Silva, Komel Younas, Fleur Cohen-Aubart, Omar Abdel-Wahab, Eli L. Diamond, Jean Donadieu, Julien Haroche
Journal: Blood Advances
Blood Adv (2023) 7 (23): 7254–7257.
https://doi.org/10.1182/bloodadvances.2023011414
Published: 2023
Includes: Supplemental data
Journal Articles

The bone marrow stroma in human myelodysplastic syndrome reveals alterations that regulate disease progression

Youmna S. Kfoury, Fei Ji, Esha Jain, Michael Mazzola, Giulia Schiroli, Ani Papazian, Francois Mercier, David B. Sykes, Anna Kiem, Mark Randolph, Laura M. Calvi, Omar Abdel-Wahab, Ruslan I. Sadreyev, David T. Scadden
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6608–6623.
https://doi.org/10.1182/bloodadvances.2022008268
Published: 2023
Includes: Supplemental data
Journal Articles

Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis

Clinical Trials & Observations
Sara Zarnegar-Lumley, Todd A. Alonzo, Robert B. Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E. Ries, Jim Wang, Amanda Leonti, Matthew A. Kutny, Fabiana Ostronoff, Jerald P. Radich, Frederick R. Appelbaum, Era L. Pogosova-Agadjanyan, Kristen O’Dwyer, Martin S. Tallman, Mark Litzow, Ehab Atallah, Todd M. Cooper, Richard A. Aplenc, Omar Abdel-Wahab, Alan S. Gamis, Selina Luger, Harry Erba, Ross Levine, E. Anders Kolb, Derek L. Stirewalt, Soheil Meshinchi, Katherine Tarlock
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5941–5953.
https://doi.org/10.1182/bloodadvances.2022008282
Published: 2023
Includes: Supplemental data
Journal Articles

Immune profiling after allogeneic hematopoietic cell transplantation in pediatric acute myeloid leukemia

Sanam Shahid, Nicholas Ceglia, Jean-Benoît Le Luduec, Andrew McPherson, Barbara Spitzer, Theodota Kontopoulos, Viktoria Bojilova, M. Kazim Panjwani, Mikhail Roshal, Sohrab P. Shah, Omar Abdel-Wahab, Benjamin Greenbaum, Katharine C. Hsu
Journal: Blood Advances
Blood Adv (2023) 7 (17): 5069–5081.
https://doi.org/10.1182/bloodadvances.2022009468
Published: 2023
Includes: Supplemental data
Journal Articles

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Clinical Trials & Observations
Maximilian Stahl, Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie, Justin Taylor, Daniel Starczynowski, Guillermo F. Sanz, David A. Sallman, Valeria Santini, Gail J. Roboz, Mrinal M. Patnaik, Eric Padron, Olatoyosi Odenike, Aziz Nazha, Stephen D. Nimer, Ravindra Majeti, Richard F. Little, Steven Gore, Alan F. List, Vijay Kutchroo, Rami S. Komrokji, Tae Kon Kim, Nina Kim, Christopher S. Hourigan, Robert P. Hasserjian, Stephanie Halene, Elizabeth A. Griffiths, Peter L. Greenberg, Maria Figueroa, Pierre Fenaux, Fabio Efficace, Amy E. DeZern, Matteo G. Della Porta, Naval G. Daver, Jane E. Churpek, Hetty E. Carraway, Andrew M. Brunner, Uma Borate, John M. Bennett, Rafael Bejar, Jacqueline Boultwood, Sanam Loghavi, Jan Philipp Bewersdorf, Uwe Platzbecker, David P. Steensma, Mikkael A. Sekeres, Rena J. Buckstein, Amer M. Zeidan
Journal: Blood Advances
Blood Adv (2023) 7 (12): 2709–2714.
https://doi.org/10.1182/bloodadvances.2022008747
Published: 2023
Journal Articles

RUNX1 deficiency cooperates with SRSF2 mutation to induce multilineage hematopoietic defects characteristic of MDS

Yi-Jou Huang, Jia-Yu Chen, Ming Yan, Amanda G. Davis, Sayuri Miyauchi, Liang Chen, Yajing Hao, Sigrid Katz, Rafael Bejar, Omar Abdel-Wahab, Xiang-Dong Fu, Dong-Er Zhang
Journal: Blood Advances
Blood Adv (2022) 6 (23): 6078–6092.
https://doi.org/10.1182/bloodadvances.2022007804
Published: 2022
Includes: Supplemental data
Journal Articles

Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML

Clinical Trials & Observations
Maximilian Stahl, Kamal Menghrajani, Andriy Derkach, Alexander Chan, Wenbin Xiao, Jacob Glass, Amber C. King, Anthony F. Daniyan, Christopher Famulare, Bernadette M. Cuello, Troy Z. Horvat, Omar Abdel-Wahab, Ross L. Levine, Aaron D. Viny, Eytan M. Stein, Sheng F. Cai, Mikhail Roshal, Martin S. Tallman, Aaron D. Goldberg
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1552–1564.
https://doi.org/10.1182/bloodadvances.2020003734
Published: 2021
Includes: Supplemental data
Journal Articles

A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease

Clinical Trials & Observations
Eli L. Diamond, Anne S. Reiner, Justin J. Buthorn, Elyse Shuk, Allison J. Applebaum, David M. Hyman, Omar Abdel-Wahab, Raajit Rampal, Filip Janku, Kathleen Brewer, Jean Campbell, Jun J. Mao, Thomas M. Atkinson, Katherine S. Panageas
Journal: Blood Advances
Blood Adv (2019) 3 (7): 934–938.
https://doi.org/10.1182/bloodadvances.2018030502
Published: 2019
Journal Articles

The clinical spectrum of Erdheim-Chester disease: an observational cohort study

Clinical Trials & Observations
Juvianee I. Estrada-Veras, Kevin J. O’Brien, Louisa C. Boyd, Rahul H. Dave, Benjamin H. Durham, Liqiang Xi, Ashkan A. Malayeri, Marcus Y. Chen, Pamela J. Gardner, Jhonell R. Alvarado Enriquez, Nikeith Shah, Omar Abdel-Wahab, Bernadette R. Gochuico, Mark Raffeld, Elaine S. Jaffe, William A. Gahl
Journal: Blood Advances
Blood Adv (2017) 1 (6): 357–366.
https://doi.org/10.1182/bloodadvances.2016001784
Published: 2017
Includes: Supplemental data